Strata Skin Sciences, Inc. (NASDAQ: SSKN) advanced in Wednesday trading, after announcing an agreement with MedResults Network, a Group Purchasing Organization that has over 3,000 members.
MRN researches product categories and selects advantaged products and then negotiates pricing for its membership. MRN focuses on the aesthetic market and has agreements with more than 50 vendors with only one vendor per product category.
Frank McCaney, CEO of the Horsham, Pa.-based company commented, “We are pleased to announce this relationship, which we believe has major benefits to STRATA. MRN has a loyal and long-term subscriber base and a reputation for providing value to its members. MRN provides additional value to its members by offering educational seminars and value to its vendors by active promotion of the products on agreement with them.”
The relationship between MRN and STRATA, which offers special pricing to MRN members, is being fully launched to the membership this week.
STRATA Skin Sciences is a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions.
Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN™ MicroSystem, marketed specifically for the intended use of micropigmentation; and Nordlys, a multi-technology aesthetic laser device.
Meantime, the company’s stock has been in a range from $1.43 to $5.40 over the last 52 weeks, and today’s developments boosted the stock price by 3.7 cents, or 2.1%, still within the bottom half of the range, at $1.79, only minutes before Wednesday’s close.
